E-Cigarette and Vaping Product Use Associated Lung Injury (EVALI)

 

E-Cigarette and Vaping Product Use Associated Lung Injury (EVALI)

Due to continued declines in new EVALI cases and the identification of vitamin E acetate as a primary cause of EVALI, the CDC has provided the information below as the final update on the number of hospitalized cases and deaths nationally:

As a of February 18, 2020, a total of 2,087 hospitalized EVALI cases or deaths have been reported to CDC from all 50 states, the District of Columbia, and two U.S. territories (Puerto Rico and U.S. Virgin Islands).  Sixty-eight deaths have been confirmed in 29 states and the District of Columbia.

EVALI cases in South Carolina mirror the national trend of declining cases.  Due to continued declines in new EVALI cases since September 2019, and the identification of vitamin E acetate as a primary cause of EVALI, this will be the final CDC update on the number of hospitalized EVALI cases and deaths nationally. CDC will continue to provide assistance to states, as needed, related to EVALI and will provide any updates at: www.cdc.gov/lunginjury.  SC DHEC will provide summary data of the EVALI impact in SC accordingly. 

 

According to the CDC, emergency department (ED) visits related to e-cigarette or vaping products continue to decline, after sharply increasing in August 2019 and peaking in September. EVALI cases in South Carolina mirror this trend. As of February 25, 2020, the CDC has transitioned from emergency response to regular programmatic efforts. The following table is a final summary of South Carolina’s EVALI findings.

Statewide Summary Data

SC EVALI Summary Feb 13, 2020

 

EVALI Hospitalization Dates 2019

 

EVALI Cases by Gender

 

EVALI Case Counts by Region

Tags

Tobacco Statewide